Rimpy Diwan
Overview
Explore the profile of Rimpy Diwan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chauhan G, Shaik A, Sawant S, Diwan R, Mokashi M, Goyal M, et al.
Biomater Adv
. 2024 Sep;
166:214027.
PMID: 39255571
Cystic fibrosis (CF) is a genetic disorder affecting nearly 105,000 patients worldwide and is characterized by poor respiratory function due to accumulation of thick mucus in the lungs, which not...
2.
Diwan R, Bhatt H, Dong R, Estevao I, Varela-Ramirez A, Nurunnabi M
J Control Release
. 2024 May;
370:421-437.
PMID: 38701884
Idiopathic pulmonary fibrosis (IPF) is a devastating lung disease with a high mortality rate due to limited treatment options. Current therapies cannot effectively reverse the damage caused by IPF. Research...
3.
Bhatt H, Diwan R, Estevao I, Dong R, Smith J, Xiao C, et al.
J Control Release
. 2024 Apr;
370():110-123.
PMID: 38648957
Continuous and aberrant activation of myofibroblasts is the hallmark of pathological fibrosis (e.g., abnormal wound healing). The deposition of excessive extracellular matrix (ECM) components alters or increases the stiffness of...
4.
Diwan R, Gaytan S, Bhatt H, Pena-Zacarias J, Nurunnabi M
Drug Deliv Transl Res
. 2024 Mar;
14(10):2743-2770.
PMID: 38446352
Liver fibrosis (LF) occurs when the liver tissue responds to injury or inflammation by producing excessive amounts of scar tissue, known as the extracellular matrix. This buildup stiffens the liver...
5.
Diwan R, Bhatt H, Beaven E, Nurunnabi M
Adv Drug Deliv Rev
. 2023 Dec;
204:115147.
PMID: 38065244
Pulmonary fibrosis (PF) is a progressive, and life-threatening interstitial lung disease which causes scarring in the lung parenchyma and thereby affects architecture and functioning of lung. It is an irreversible...
6.
Bhatt H, Diwan R, Borrego E, Martinez Perez C, Varela-Ramirez A, Kumar R, et al.
J Control Release
. 2023 Aug;
361:314-333.
PMID: 37562554
Solid tumors are abnormal mass of tissue, which affects the organs based on its malignancy and leads to the dysfunction of the affected organs. The major problem associated with treatment...
7.
Esquivel S, Bhatt H, Diwan R, Habib A, Lee W, Khatun Z, et al.
Biomolecules
. 2023 May;
13(5).
PMID: 37238639
The oral route is considered the most convenient route of drug administration for both systemic and local delivery. Besides stability and transportation, another unmet but important issue regarding oral medication...
8.
Bhatt H, Pena-Zacarias J, Beaven E, Zahid M, Ahmad S, Diwan R, et al.
ACS Appl Bio Mater
. 2023 Feb;
6(2):365-383.
PMID: 36753355
Over the last decades, photomedicine has made a significant impact and progress in treating superficial cancer. With tremendous efforts many of the technologies have entered clinical trials. Photothermal agents (PTAs)...
9.
Diwan R, Ravi P, Agarwal S, Aggarwal V
Pharm Dev Technol
. 2020 Dec;
26(3):278-290.
PMID: 33319618
Cilnidipine (CND), an anti-hypertensive drug, possesses low oral bioavailability due to its poor aqueous solubility, low dissolution rate, and high gut wall metabolism. In the present study, an attempt has...
10.
Diwan R, Ravi P, Pathare N, Aggarwal V
Colloids Surf B Biointerfaces
. 2020 May;
193:111073.
PMID: 32388122
Cilnidipine (CND), an anti-hypertensive drug, is known to have low oral bioavailability due to its poor aqueous solubility, low dissolution rate and high gut wall metabolism. In the present study,...